Trial · NCT07913568
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Objective Response Rate (ORR) assessed by the central review | Baseline up to 3 years. Overall Response is assessed every 8 weeks until 24 weeks after initiation of protocol treatment, and every 12 weeks after 25 weeks and after termination. It continues until PD confirmation or post-study treatment initiation. | |
| Secondary | Objective Response Rate (ORR) as assessed by the investigator (site assessment) | Baseline up to 3 years. Overall Response is assessed every 8 weeks until 24 weeks after initiation of protocol treatment, and every 12 weeks after 25 weeks and after termination. It continues until PD confirmation or post-study treatment initiation. | |
| Secondary | Progression-Free Survival (PFS) | From baseline up to 3 years | |
| Secondary | Overall Survival (OS) | From baseline up to 3 years | |
| Secondary | Disease Control Rate (DCR) | From baseline up to 3 years | |
| Secondary | Incidence of adverse events | From baseline up to 3 years | |
| Secondary | Incidence of Adverse Reactions | From baseline up to 3 years | |
| Secondary | Incidence of Serious Adverse Events/ Adverse Reactions | From baseline up to 3 years | |
| Secondary | Duration of Response (DoR) | From baseline up to 3 years | |
| Secondary | Time to Response (TTR) | From baseline up to 3 years | |
| Secondary | EORTC QLQ-C30 | From baseline up to 3 years | The score range is 0-100 (minimum: 0; maximum: 100). Global health status/QOL: Higher standardized scores indicate better outcomes. Symptom scales/items: Higher standardized scores indicate worse outcomes. |
| Secondary | QLQ-OV28 | From baseline up to 3 years | The score range is 0-100 (minimum: 0; maximum: 100). Symptom scales/items: Higher standardized scores indicate worse outcomes. |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07913568/registered